In conclusion, oxytocin and its analogs have multi-level effects in improving weight control, insulin sensitivity and insulin secretion, and bear potentials for being developed as therapeutic peptides for obesity and diabetes. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.